Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

179 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
ICON 9-an international phase III randomized study to evaluate the efficacy of maintenance therapy with olaparib and cediranib or olaparib alone in patients with relapsed platinum-sensitive ovarian cancer following a response to platinum-based chemotherapy.
Elyashiv O, Ledermann J, Parmar G, Farrelly L, Counsell N, Feeney A, El-Khouly F, Macdonald I, Neto A, Arthur-Darkwa E, Burnett E, Jayson GC, Mileshkin L, Gourley C, Nicum S. Elyashiv O, et al. Among authors: burnett e. Int J Gynecol Cancer. 2021 Jan;31(1):134-138. doi: 10.1136/ijgc-2020-002073. Epub 2020 Oct 23. Int J Gynecol Cancer. 2021. PMID: 33097567
Site staff perspectives on communicating trial results to participants: Cost and feasibility results from the Show RESPECT cluster randomised, factorial, mixed-methods trial.
South A, Bailey J, Bierer BE, Burnett E, Cragg WJ, Diaz-Montana C, Gillies K, Isaacs T, Joharatnam-Hogan N, Snowdon C, Sydes MR, Copas AJ. South A, et al. Among authors: burnett e. Clin Trials. 2023 Dec;20(6):649-660. doi: 10.1177/17407745231186088. Epub 2023 Jul 29. Clin Trials. 2023. PMID: 37515519 Free PMC article.
Rotavirus vaccine effectiveness stratified by national-level characteristics: an introduction to the 24-country MNSSTER-V Project, 2007-2023.
Burnett E, Umana J, Anwari P, Mujuru HA, Groome MJ, Van Trang N, Iniguez V, Gheorghita S, Sahakyan G, Nazurdinov A, Michael F, Mandomando I, Desormeaux AM, Eraliev U, Enweronu-Laryea C, Nalunkuma C, Bonkoungou I, Muhsen K, Luhata Lungayo C, Omore R, Goldfarb DM, Robinson AL, McCracken J, Uwimana J, N'Zue K, Rey-Benito G, Weldegebriel G, Mwenda JM, Parashar UD, Tate JE; Multi-national subpopulations study to evaluate rotavirus vaccines (MNSSTER-V) project working group. Burnett E, et al. J Infect Dis. 2024 Nov 28:jiae597. doi: 10.1093/infdis/jiae597. Online ahead of print. J Infect Dis. 2024. PMID: 39607893
Monovalent rotavirus vaccine effectiveness and long-term impact among children <5 years old in Antananarivo, Madagascar, 2010-2022.
Raboba JL, Rahajamanana VL, Rakotojoelimaria HE, Masembe YV, Martin PR, Weldegebriel GG, Diallo AO, Burnett E, Tate JE, Parashar UD, Mwenda JM, Seheri M, Magagula N, Mphahlele J, Robinson AL. Raboba JL, et al. Among authors: burnett e. Vaccine. 2024 Dec 2;42(26):126321. doi: 10.1016/j.vaccine.2024.126321. Epub 2024 Sep 10. Vaccine. 2024. PMID: 39260057
Indirect protection from rotavirus vaccines: a systematic review.
Chavers T, Cates J, Burnett E, Parashar UD, Tate JE. Chavers T, et al. Among authors: burnett e. Expert Rev Vaccines. 2024 Jan-Dec;23(1):789-795. doi: 10.1080/14760584.2024.2395534. Epub 2024 Sep 1. Expert Rev Vaccines. 2024. PMID: 39167375 Free article. Review.
179 results